Scabies

Tropical Dermatology

Volumn , Issue , 2006, Pages 375-385

  Currie, Bart ^a   Hengge, Ulrich R ^b  

^a CHARLES DARWIN UNIVERSITY   (Australia)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248220782     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06790-7.50033-8     Document Type: Chapter

References (23)

1. Alexander JO Scabies. Arthropods and human skin 1984, 227-292. Springer-Verlag, New York.
2. Montesu M, Cottoni F, Bonomo GC, et al. Discoverers of the parasitic origin of scabies. Am J Dermatopathol 1991, 13:425-427.
3. Green MS Epidemiology of scabies. Epidemiol Rev 1989, 11:126-150.
4. Mellanby K The development of symptoms, parasitic infection and immunity in human scabies. Parasitology 1944, 35:197-206.
5. Arlian LG, Morgan MS, Rapp CM, et al. The development of protective immunity in canine scabies. Vet Parasitol 1996, 62:133-142.
6. Chosidow O Scabies and pediculosis. Lancet 2000, 355:819-826.
7. Walton SF, Holt DC, Currie BJ, et al. Scabies: new future for a neglected disease. Adv Parasitol 2004, 57:309-376.
8. Taplin D, Porcelain SL, Meinking TL, et al. Community control of scabies: a model based on use of permethrin cream. Lancet 1991, 337:1016-1018.
9. Fain A Epidemiological problems of scabies. Int J Dermatol 1978, 17:20-30.
10. Arlian LG, Morgan MS, Arends JJ Immunologic cross-reactivity among various strains of Sarcoptes scabiei. J Parasitol 1996, 82:66-72.
11. Walton SF, Choy JL, Bonson A, et al. Genetically distinct dog-derived and human-derived Sarcoptes scabiei in scabies-endemic communities in northern Australia. Am J Trop Med Hyg 1999, 61:542-547.
12. Meinking TL, Taplin D, Hermida JL, et al. The treatment of scabies with ivermectin. N Engl J Med 1995, 333:26-30.
13. Huffam SE, Currie BJ Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis 1998, 2:152-154.
14. Cabrera R, Dahl MV The immunology of scabies. Semin Dermatol 1993, 12:15-21.
15. Walker GJ, Johnstone PW Interventions for treating scabies. Cochrane Database Syst Rev 2000, CD000320.
16. Roos TC, Alam M, Roos S, et al. Pharmacotherapy of ectoparasitic infections. Drugs 2001, 61:1067-1088.
17. Schultz M, Gomez M, Hansen R, et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990, 126:167-170.
18. Chouela EN, Abeldano AM, Pellerano G, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999, 135:651-655.
19. Davies JE, Dedhia HV, Morgade C, et al. Lindane poisonings. Arch Dermatol 1983, 119:142-144.
20. Roth W Scabies resistant to lindane 1% lotion and crotamiton 10% cream. J Am Acad Dermatol 1991, 24:502-503.
21. Usha V, Gopalakrishnan Nair TV A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000, 42:236-240.
22. Currie BJ, Harumal P, McKinnon M, et al. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004, 39:E8-E12.
23. Wong L, Amega B, Barker R, et al. Factors supporting sustain-ability of a community-based scabies control program. Australas J Dermatol 2002, 43:274-277.